Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit
RSC Medicinal Chemistry · 2025 · 16 (9) · 4068-4090
DOI: 10.1039/d5md00316d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Peiqin Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London London SE1 9NH UK k.miraz.rahman@kcl.ac.uk. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Here we describe the design, synthesis and validation of the first NF-κB PROTAC degrader with demonstrable subunit selectivity for RelA/p65.
Autor:innen und Institutionen
- Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London London SE1 9NH UK k.miraz.rahman@kcl.ac.uk.
- Brighton and Sussex Medical School, University of Brighton and University of Sussex Brighton BN1 9PX UK c.pepper@bsms.ac.uk.
ORCID-Profile: Peiqin Jin, Khondaker Miraz Rahman, Chris Pepper
Zitieren
APA
Jin, P., Hasan, M. M., Pepper, A. G. S., Mitchell, S., Rahman, K. M., & Pepper, C. (2025). Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit. RSC Medicinal Chemistry, 16(9), 4068-4090. https://doi.org/10.1039/d5md00316d
Vancouver
Jin P, Hasan MM, Pepper AGS, Mitchell S, Rahman KM, Pepper C. Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit. RSC Medicinal Chemistry. 2025;16(9):4068-4090. doi:10.1039/d5md00316d
BibTeX
@article{Jin2025,
author = {Jin, Peiqin and Hasan, Md Mahbub and Pepper, Andrea G S and Mitchell, Simon and Rahman, Khondaker Miraz and Pepper, Chris},
title = {Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {9},
pages = {4068--4090},
doi = {10.1039/d5md00316d}
}
EUVIMED